Disrupt Health Impact Fund
We invest in early-stage, global healthcare startups. Within biotech, we focus on early risk detection and diagnostics. Therapeutics and surgical solutions are currently outside our investment scope.
)
January 11-14, 2027 | San Francisco
January 11-14, 2027 | San Francisco
)
)
January 11-14, 2027 | San Francisco
){kind=logo}
){kind=logo}
)